GR
NYSE · GRX
The Gabelli Healthcare & Wellness Trust
Financial Services · Asset Management
$9.85
Up+$0.13 (+1.34%)
Updated Sep 15, 2026, 11:19 AM
SID Score
4.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 151.54M
- P/E ratio
- -215.13
- Dividend yield
- 8.22%
- 52-week range
- $8.80 – $10.20
- Volume
- 11.02K
- Avg. volume
- 34.22K
Price performance
GRX price history
1M range · 20 trading sessions · Daily adjusted prices
GRX closed at $9.85 after 20 trading sessions, down 0.35% for the selected period.
- Last close
- $9.85
- Period change
- -0.35%
- Period low
- $9.72
- Period high
- $10.17
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 14, 2026 | $9.74 | $9.8999 | $9.74 | $9.85 | 11.02K |
| Sep 11, 2026 | $9.79 | $9.79 | $9.71 | $9.72 | 10.96K |
| Sep 10, 2026 | $9.86 | $9.86 | $9.71 | $9.74 | 27.42K |
| Sep 9, 2026 | $9.89 | $9.92 | $9.89 | $9.89 | 26.53K |
| Sep 8, 2026 | $9.98 | $10.00 | $9.92 | $9.93 | 25.27K |
| Sep 4, 2026 | $10.02 | $10.055 | $10.02 | $10.03 | 7.58K |
| Sep 3, 2026 | $10.01 | $10.15 | $10.01 | $10.09 | 33.86K |
| Sep 2, 2026 | $10.04 | $10.125 | $10.04 | $10.09 | 5.6K |
| Sep 1, 2026 | $10.02 | $10.095 | $9.929 | $10.04 | 13.91K |
| Aug 31, 2026 | $10.01 | $10.115 | $10.00 | $10.01 | 25.19K |
| Aug 28, 2026 | $10.07 | $10.10 | $10.03 | $10.06 | 19.13K |
| Aug 27, 2026 | $10.10 | $10.17 | $10.02 | $10.05 | 25.86K |
| Aug 26, 2026 | $10.17 | $10.19 | $10.10 | $10.10 | 32.46K |
| Aug 25, 2026 | $10.15 | $10.1999 | $10.14 | $10.17 | 13.48K |
| Aug 24, 2026 | $10.20 | $10.20 | $10.10 | $10.15 | 26.13K |
| Aug 21, 2026 | $10.04 | $10.1796 | $10.015 | $10.14 | 44.57K |
| Aug 20, 2026 | $10.13 | $10.1499 | $10.00 | $10.03 | 40.79K |
| Aug 19, 2026 | $9.98 | $10.17 | $9.97 | $10.15 | 95.99K |
| Aug 18, 2026 | $9.88 | $10.00 | $9.88 | $9.92 | 22.75K |
| Aug 17, 2026 | $9.91 | $9.95 | $9.88 | $9.885 | 9.23K |
Latest GRX news
The latest Smart Investors Daily articles mentioning GRX.
Stock researchResearch & News · Analysis
Loading stock research…
